• Issue

    CNS Neuroscience & Therapeutics: Volume 30, Issue 4

    April 2024

COVER IMAGE

Open Access

Front Cover

  • First Published: 16 April 2024
Front Cover Volume 30 Issue 4, 2024

The cover image is based on the Commentary Non-scheduled short acting opioid to taper off opioids? by Renyu Liu et al., https://doi.org/10.1111/cns.14705.

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 01 April 2024

ORIGINAL ARTICLES

Open Access

Molecular mechanism analyses of post-traumatic epilepsy and hereditary epilepsy based on 10× single-cell transcriptome sequencing technology

  • First Published: 04 April 2024
Molecular mechanism analyses of post-traumatic epilepsy and hereditary epilepsy based on 10× single-cell transcriptome sequencing technology

The reads obtained from 10× genomic platform of traumatic epilepsy and hereditary epilepsy were 39.56 M and 30.08 M. The Q30 of RNA reads over 91.6%. After filtering, 7479 traumatic epilepsy and 9357 hereditary epilepsy cells were left for further study. Over 96.4% of the reads are mapped to GRCh38/GRCm38. The cells were differentially distributed in two groups, with higher oligodendrocytes (6522 vs. 2532) and astrocytes (133 vs. 52), lower microglia (2242 vs. 3811) and neurons (3 vs. 203) were observed in hereditary epilepsy than traumatic epilepsy. The DEGs in four cell clusters were identified, with 25 in oligodendrocytes (13 upregulated and 12 downregulated), 87 in microglia (42 upregulated and 45 downregulated), 222 in astrocytes (115 upregulated and 107 downregulated), and 393 in neurons (305 upregulated and 88 downregulated). MTND1P23 (downregulated), XIST (downregulated), and RPS4Y1 (upregulated) were commonly expressed in four cell clusters. The DEGs in microglia and astrocytes were enriched in IL-17 signaling pathway. Our study explored the cell grouping between traumatic and hereditary epilepsy, and the transcriptome in different cells for the first time. Inflammatory and immune functions might be the main approaches in traumatic temporal lobe epilepsy of neurons.

Open Access

SIRT3 alleviates painful diabetic neuropathy by mediating the FoxO3a-PINK1-Parkin signaling pathway to activate mitophagy

  • First Published: 04 April 2024
SIRT3 alleviates painful diabetic neuropathy by mediating the FoxO3a-PINK1-Parkin signaling pathway to activate mitophagy

Painful diabetic neuropathy in the dorsal root ganglion (DRG) induces mitochondrial impairment and sirtuin 3 deficiency, leading to inhibited mitophagy through the FoxO3a-PINK1-Parkin pathway, exacerbating allodynia.

Open Access

Stigmasterol alleviates neuropathic pain by reducing Schwann cell-macrophage cascade in DRG by modulating IL-34/CSF1R

  • First Published: 04 April 2024
Stigmasterol alleviates neuropathic pain by reducing Schwann cell-macrophage cascade in DRG by modulating IL-34/CSF1R

Stigmasterol reduces the cascade reaction of Schwann cells and macrophages by regulating the IL34/CSF1R axis, and reduces the peripheral sensitization caused by neuroinflammation in the dorsal root ganglia (DRG), thereby alleviating neuropathic pain.

REVIEWS

Open Access

The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy

  • First Published: 04 April 2024
The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy

The potential of phosphorylated α-Syn (p-syn) as a biomarker for multiple system atrophy diagnosis and monitoring, is defined by the abnormal p-syn accumulation in the brain and peripheral tissues.

ORIGINAL ARTICLES

Open Access

AZD1390, an ataxia telangiectasia mutated inhibitor, attenuates microglia-mediated neuroinflammation and ischemic brain injury

  • First Published: 26 April 2024
AZD1390, an ataxia telangiectasia mutated inhibitor, attenuates microglia-mediated neuroinflammation and ischemic brain injury

AZD1390 suppressed NF-κB signaling pathway through restricting ubiquitylation and sumoylation of NEMO, which alleviated ischemic brain injury in experimental stroke and attenuated the activation of microglia and neuroinflammation.

Open Access

Spontaneous brain activity in the hippocampal regions could characterize cognitive impairment in patients with Parkinson's disease

  • First Published: 07 April 2024
Spontaneous brain activity in the hippocampal regions could characterize cognitive impairment in patients with Parkinson's disease

Spontaneous brain activity (fractional amplitude of low-frequency fluctuation − fALFF) in the hippocampal regions could reveal cognitive levels in patients with Parkinson's disease to differentiate normal cognition, mild cognitive impairment, and severe cognitive impairment.

Open Access

Mitochondria-associated endoplasmic reticulum membranes tethering protein VAPB-PTPIP51 protects against ischemic stroke through inhibiting the activation of autophagy

  • First Published: 07 April 2024
Mitochondria-associated endoplasmic reticulum membranes tethering protein VAPB-PTPIP51 protects against ischemic stroke through inhibiting the activation of autophagy

The downregulation of VAPB-PTPIP51 expression after ischemic stroke mediates structural damage to mitochondria-associated endoplasmic reticulum membranes, which may exacerbate CIRI by regulating the PI3K pathway and activating autophagy.

REVIEWS

Open Access

Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies

  • First Published: 07 April 2024
Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies

This review delves into the intricate relationship between the gut microbiota and Alzheimer's disease (AD), unraveling the close association between microbial changes and disease mechanisms. By elucidating relevant pathways, we present promising therapeutic strategies involving the modulation of the gut microbiota, opening new avenues for innovative treatments in AD. Graphical Abstract created By Figdraw.

EDITORIAL COMMENTARY

Open Access

Non-scheduled short-acting opioid to taper off opioids?

  • First Published: 07 April 2024
Non-scheduled short-acting opioid to taper off opioids?

In this perspective, we are proposing to introduce a non-scheduled short-acting opioid into clinical practice given the significant need to find alternatives to taper off opioids and bridge buprenorphine and methadone therapies for opioid use disorders. Dezocine, a previously FDA approved non-scheduled opioid for pain management, is a potential candidate to explore. Dr. Renyu Liu obtained the images presented in this graphic abstract from Adobe Stock with standard licenses.

ORIGINAL ARTICLES

Open Access

DMT1 ubiquitination by Nedd4 protects against ferroptosis after intracerebral hemorrhage

  • First Published: 18 April 2024
DMT1 ubiquitination by Nedd4 protects against ferroptosis after intracerebral hemorrhage

Upon ICH, the brain's DMT1 increased but decreased with Lentivirus-induced Nedd4 overexpression, implying a negative correlation. Nedd4 interacted with DMT1 at lysine residues 6, 69, and 277, resulting in ubiquitination and degradation of DMT1. Nedd4 overexpression relieved ferroptosis and aided ICH recovery, as indicated by functional analysis.

REVIEWS

Open Access

mTOR signaling and Alzheimer's disease: What we know and where we are?

  • First Published: 18 September 2023
mTOR signaling and Alzheimer's disease: What we know and where we are?

mTOR signaling and Alzheimer's disease (AD). Upregulation of mTOR activity appears to be involved in the main pathological cascade of AD, and mTOR inhibition or targeting its downstream substrates could supply attractive avenues for AD treatment.

Open Access

The role of NMDARs in the anesthetic and antidepressant effects of ketamine

  • First Published: 07 September 2023
The role of NMDARs in the anesthetic and antidepressant effects of ketamine

The NMDAR inhibition is the primary presumptive molecular mechanism underlying the anesthetic and antidepressant effects of ketamine.

Open Access

NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease

  • First Published: 22 September 2023
NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease

The potential synergistically ncRNA-based apoptosis regulatory mechanism exists in AD.

Open Access

How inflammation dictates diabetic peripheral neuropathy: An enlightening review

  • First Published: 05 October 2023
How inflammation dictates diabetic peripheral neuropathy: An enlightening review

Understanding the role of inflammation in diabetic peripheral neuropathy's progression.

Open Access

Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression

  • First Published: 06 November 2023
Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression

The pathophysiology and treatment in the comorbidity of diabetes mellitus and depression. GM, Gastrointestinal Microbiome; HPA, Hypothalamic–Pituitary–Adrenal. By Figdraw.

Open Access

Regulatory mechanism of circular RNAs in neurodegenerative diseases

  • First Published: 21 October 2023
Regulatory mechanism of circular RNAs in neurodegenerative diseases

CircRNAs influence neurodegenerative pathologies mainly by affecting the abnormal deposition of proteins in neurodegenerative diseases.

Open Access

The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors

  • First Published: 12 November 2023
The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors

The precise risk factors and molecular mechanisms underlying CNS tumors remain unverified. Growing evidence suggests that Circular RNAs (circRNAs) have numerous significant biological functions in disease progression. In this review, we provide an overview of the relationship between circRNAs and CNS tumors and discuss the diagnostic and therapeutic potential of circRNAs in CNS tumors.

ORIGINAL ARTICLES

Open Access

The prevalence and risk factors study of cognitive impairment: Analysis of the elderly population of Han nationality in Hunan province, China

  • First Published: 22 September 2023
The prevalence and risk factors study of cognitive impairment: Analysis of the elderly population of Han nationality in Hunan province, China

We performed a cross-sectional study on the cognitive function of the Han elderly population in southern China and the target population coverage rate was high, reaching 73%. A representative prevalence rate of cognitive impairment was obtained, and the relevant risk factors were comprehensively analyzed.

Open Access

Genome-wide DNA methylation analysis identifies potent CpG signature for temzolomide response in non-G-CIMP glioblastomas with unmethylated MGMT promoter: MGMT-dependent roles of GPR81

  • First Published: 13 October 2023
Genome-wide DNA methylation analysis identifies potent CpG signature for temzolomide response in non-G-CIMP glioblastomas with unmethylated MGMT promoter: MGMT-dependent roles of GPR81

By analyzing DNA methylation microarray data and clinical information of glioblastomas (GBMs) that do not have glioma-CpGs island methylator phenotype (G-CIMP) but have an unmethylated promoter of O-6-methylguanine-DNA methyltransferase (unMGMT), a panel of 64 CpGs and a 10-CpG risk score signature were discovered and validated with specific linkage to temozolomide (TMZ) efficacy. Experimental data provided biological clues behind the risk signature. The 64 CpGs and in particular the 10-CpG signature may serve as promising predictive biomarker candidates for guiding optimal usage of TMZ in GBMs with G-CIMP- and unMGMT.

Open Access

Impaired neural circuitry of hippocampus in Pax2 nervous system-specific knockout mice leads to restricted repetitive behaviors

  • First Published: 03 October 2023
Impaired neural circuitry of hippocampus in Pax2 nervous system-specific knockout mice leads to restricted repetitive behaviors

The Nestin-Pax2 mice showed increased RRBs at both lower-order and higher-order. Furthermore, alterations in the mPFC→CA1/BLA neural circuitry and a reduction in IGFBP2 can be found in the hippocampus.

Open Access

Integrated transcriptomic and proteomic profiling reveals the key molecular signatures of brain endothelial reperfusion injury

  • First Published: 03 October 2023
Integrated transcriptomic and proteomic profiling reveals the key molecular signatures of brain endothelial reperfusion injury

Transcriptomic analysis of human cerebral microvascular endothelial cell (HCMEC)/D3 cells subjected to OGD/R showed that the top significantly changed signaling pathways were mostly associated with inflammatory responses, especially the TNF signaling pathway. Reperfusion-induced differentially expressed proteins were primarily involved in extracellular matrix destruction and remodeling, impairment of endothelial transport function, and inflammatory responses.

Open Access

A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

  • First Published: 18 October 2023
A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

A TGF-β signaling-related lncRNA signature has been established in glioma, which can be used for prognostic judgment, immune infiltration status speculation, and immunotherapy response prediction. Furthermore, in vitro experiments confirmed that silencing of TGF-β signaling-related lncRNA could inhibit the proliferation of glioma cells. This study provides candidate biomarkers with clinical application value for glioma.

Open Access

Disrupted functional connectivity of the habenula links psychomotor retardation and deficit of verbal fluency and working memory in late-life depression

  • First Published: 07 October 2023
Disrupted functional connectivity of the habenula links psychomotor retardation and deficit of verbal fluency and working memory in late-life depression

Patients with late-life depression (LLD) exhibited decreased static FC between the right habenula and bilateral IFG compared with healthy controls, and this decreased FC was involved in the underlying pathway connecting psychomotor retardation and deficit of verbal fluency and working memory. The present results provide a more in-depth understanding of their pathological mechanism, and could inform the development of more targeted and effective therapeutic interventions, improving the management and treatment outcomes for LLD.

Open Access

The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease

  • First Published: 21 October 2023
The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease

The quantitative visual score medial temporal lobe atrophy index (QMTA) can be utilized as a clinical diagnostic tool for Alzheimer's disease. When the QMTA value is 0.635 or higher, it may indicate probable Alzheimer's disease.

Open Access

Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF-mediated Bcl-x exon 2b inclusion

  • First Published: 21 October 2023
Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF-mediated Bcl-x exon 2b inclusion

The full length Dyrk1A phosphorylated ASF and inhibited ASF-mediated Bcl-xL exon 2b inclusion leading to cell apoptosis. Moreover, the truncated Dyrk1A deleting the C-terminus exhibited equidistribution in the nucleoplasm and stronger interaction with ASF, leading to decreased ratio of Bcl-xL/Bcl-xS and neuronal apoptosis in AD.

Open Access

Expression and metabolism profiles of CVT associated with inflammatory responses and oxygen carrier ability in the brain

  • First Published: 30 October 2023
Expression and metabolism profiles of CVT associated with inflammatory responses and oxygen carrier ability in the brain

Adult rats were subjected to CVT and MCAO models. Multi-omics (RNA-seq and untargeted metabolomics) analysis were performed to construct the transcriptome and metabolism profiles of rat brains after CVT and also MCAO. The differential gene analysis, functional annotation, and enrichment analysis were also performed.

Open Access

The guiding effect of local field potential during deep brain stimulation surgery for programming in Parkinson's disease patients

  • First Published: 13 October 2023
The guiding effect of local field potential during deep brain stimulation surgery for programming in Parkinson's disease patients

Gamma oscillations and the beta/alpha oscillations ratio are potential biomarkers for programming after DBS in PD patients.

Open Access

Association between nutritional status and gait performance in Alzheimer's disease

  • First Published: 10 November 2023
Association between nutritional status and gait performance in Alzheimer's disease

Alzheimer's disease (AD) patients in the dementia stage had worse nutritional status and gait performance than those in the MCI stage. Poorer nutritional status was associated with poorer gait performance in AD patients.

Open Access

Eomesodermin expression in CD4+T-cells associated with disease progression in amyotrophic lateral sclerosis

  • First Published: 18 October 2023
Eomesodermin expression in CD4+T-cells associated with disease progression in amyotrophic lateral sclerosis

Eomesodermin was highly expressed in the peripheral CD4+T-cells derived from ALS patients. Elevated CXCR3 expression in CD4+EOMES+ T-cells differentiates ALS from HCs. EOMES+ subsets were correlated with serum NFL levels. ALS patients with higher EOMES expression were associated with higher progression rates and worse prognosis.

Open Access

Anti-PD-1 treatment protects against seizure by suppressing sodium channel function

  • First Published: 30 October 2023
Anti-PD-1 treatment protects against seizure by suppressing sodium channel function

The blockade of PD-1 alleviates neuronal overexcitation by reinstating sodium channel inactivation, indicating anti-PD-1 treatment as a novel therapeutic strategy for epilepsy.

Open Access

The association between hemoglobin concentration and clinical outcomes after aneurysmal subarachnoid hemorrhage: Insights from the LongTEAM registry

  • First Published: 17 October 2023
The association between hemoglobin concentration and clinical outcomes after aneurysmal subarachnoid hemorrhage: Insights from the LongTEAM registry

Our findings demonstrate a significant correlation between preoperative high HGB concentrations and the occurrence of DVT following aSAH. This highlights the potential of HGB as an early indicator for identifying patients at high risk of developing DVT.

Open Access

Nicotine suppresses crystalline silica-induced astrocyte activation and neuronal death by inhibiting NF-κB in the mouse hippocampus

  • First Published: 21 October 2023
Nicotine suppresses crystalline silica-induced astrocyte activation and neuronal death by inhibiting NF-κB in the mouse hippocampus

Pattern diagram illustrating the alleviation of depression induced by crystalline silica through nicotine intervention. Upon exposure to CS, the blood–brain barrier (BBB) in the hippocampus undergoes damage, leading to activation of astrocytes and microglia. The activated astrocytes facilitate the secretion of Lcn2 via the NF-κB pathway, ultimately resulting in neuronal death. However, nicotine mitigates the activation of astrocytes and microglia while safeguarding neurons against cell death.

Open Access

Survivin enhances hippocampal neurogenesis and cognitive function in Alzheimer's disease mouse model

  • First Published: 30 October 2023
Survivin enhances hippocampal neurogenesis and cognitive function in Alzheimer's disease mouse model
GA

Survivin is able to regulate neurogenesis in vitro and in vivo model. Our results demonstrate that therapeutic effects of survivin which improves cognitive function by enhancing neurogenesis in 5XFAD mouse. Survivin seems to be a good candidate for therapeutics to restore cognitive function in hippocampus of AD.

Open Access

Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics

  • First Published: 31 October 2023
Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics

sEH inhibition reduced pro-inflammatory processes in vitro and in vivo models, being the eIF2α/CHOP, an undescribed implicated neuroprotective pathway improving cognition and AD hallmarks in 5XFAD mice model by favoring synaptic plasticity, modulating ISR, and apoptosis.

Open Access

Circular RNA PTP4A2 regulates microglial polarization through STAT3 to promote neuroinflammation in ischemic stroke

  • First Published: 23 October 2023
Circular RNA PTP4A2 regulates microglial polarization through STAT3 to promote neuroinflammation in ischemic stroke

After cerebral ischemia, circPTP4A2 levels increased in peri-infarct cortex and the elevation of circPTP4A2 was mainly located in microglia. Upregulated circPTP4A2 directly binds to STAT3 and promoted STAT3 phosphorylation activation. The phosphorylated STAT3 dimer then enters the nucleus to modulate stroke-induced microglial polarization, which promotes neuroinflammation by driving M1 microglial polarization.

Open Access

Asymmetric deep cerebral venous filling predicts poor outcome of acute basilar artery occlusion after endovascular treatment

  • First Published: 12 November 2023
Asymmetric deep cerebral venous filling predicts poor outcome of acute basilar artery occlusion after endovascular treatment

In patients with acute basilar artery occlusion with asymmetric deep cerebral venous filling, the risk of postoperative malignant cerebellar edema and adverse outcome at 90-day follow-up is significantly increased even after complete recanalization.

Open Access

Emerging trends and hotspots of the itch research: A bibliometric and visualized analysis

  • First Published: 30 October 2023
Emerging trends and hotspots of the itch research: A bibliometric and visualized analysis

This study conducted a comprehensive bibliometric and visual analysis of itch research. 2314 papers closely related to itch research published between 2002 and 2021 were retrieved from the SCI-E of Web of Science Core Collection database. Full records and cited references were extracted from relevant publications. Then the data were imported into the Online Analysis Platform of Biobliometry, VOSviewer, CiteSpace software, and Bibliometrix to systematically evaluate publication trends in itch research and predict future research directions.

Open Access

Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease

  • First Published: 31 October 2023
Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease

Carpesii fructus extract (CFE) attenuates H2O2- or 6-OHDA-induced toxicity and reduce α-synuclein to inhibit ROS production and restore MMP in PC-12 cells and Caenorhabditis elegans, resulting in the improvement of dopaminergic neurons and motor ability in PD. These effects are involved the regulation of MAPK signaling pathway.

Open Access

Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study

  • First Published: 31 October 2023
Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study

As quantified by multiple scale entropy (MSE), tremor complexity may be a promising marker to capture the pathophysiology underlying the development of Parkinsonian tremor (PT), and help characterize the effects of medication on the complex regulation of PT.

Open Access

Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence

  • First Published: 06 November 2023
Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence

Overall, findings indicate the generation of therapeutic benefits through the simultaneous intravenous and intranasal administration of secretome derived from preconditioned human mesenchymal stem cells, which helps mitigate morphine-induced withdrawal syndrome in two relevant animal models of morphine dependence. These effects were associated with a reduction of morphine-induced neuroinflammation in the hippocampus and nucleus accumbens.

Open Access

Novel subsets of peripheral immune cells associated with promoting stroke recovery in mice

  • First Published: 31 October 2023
Novel subsets of peripheral immune cells associated with promoting stroke recovery in mice
Brief abstract

The role of peripheral immune cells in stroke recovery remains unclear. Gu et al. report a phagocytic subset of macrophages and a macrophage-like subset of T cells enhancing brain repair, while natural killer cells decrease cytotoxicity and neutrophils keep cell recruitment. These identified immune components may provide potential therapeutic targets.

Open Access

Zhi Zi Chi decoction (Gardeniae fructus and semen Sojae Praeparatum) attenuates anxious depression via modulating microbiota–gut–brain axis in corticosterone combined with chronic restraint stress-induced mice

  • First Published: 31 October 2023
Zhi Zi Chi decoction (Gardeniae fructus and semen Sojae Praeparatum) attenuates anxious depression via modulating microbiota–gut–brain axis in corticosterone combined with chronic restraint stress-induced mice

ZZCD exerts pleiotropic antidepressant effects by regulating HPA axis and gut microbiota, participating in the process of neuroactive ligand/receptor interaction, regulating the secretion of prolactin and estrogen, and interfering with MAPK and TNF signaling pathways to reduce inflammation levels.

Open Access

A neural circuit associated with anxiety-like behaviors induced by chronic inflammatory pain and the anxiolytic effects of electroacupuncture

  • First Published: 29 November 2023
A neural circuit associated with anxiety-like behaviors induced by chronic inflammatory pain and the anxiolytic effects of electroacupuncture

Chronic inflammatory pain induces anxiety-like behaviors, and electroacupuncture ameliorates negative emotions by intervening rACCCaMKII-DRN5-HT neural circuit but not the rACCCaMKII-DRNGABA circuit.

Open Access

Psychiatric disorders associated with PCSK9 inhibitors: A real-world, pharmacovigilance study

  • First Published: 10 November 2023
Psychiatric disorders associated with PCSK9 inhibitors: A real-world, pharmacovigilance study

This pharmacovigilance study is based on real-world data from the FAERS database. Total AEs between the third quarter of 2015 and the first quarter of 2023 were obtained from FAERS. Psychiatric AEs were identified using disproportionality analysis and clinical prioritization of signals using a rating scale, followed by univariate logistic regression to explore factors influencing psychiatric AEs.

Open Access

Abnormal regional activity in the prefrontal-limbic circuit at rest: Potential imaging markers and treatment predictors in drug-naive anxiety disorders

  • First Published: 21 November 2023
Abnormal regional activity in the prefrontal-limbic circuit at rest: Potential imaging markers and treatment predictors in drug-naive anxiety disorders

This study aims to explore the regional activity within the prefrontal-limbic circuit among drug-naive individuals diagnosed with GAD and panic disorder (PD) and to analyze changes following treatment. To our knowledge, this study is the first to explore the regional activity within the prefrontal-limbic system circuitry using a finely tuned Brainnetome atlas. A major strength of this study is that the abnormal regional activity in the right cHipp subregion of the hippocampus, left A23d and bilateral A32sg subregions of the cingulate, as well as the left A14m and bilateral A12/47L subregions of the orbitofrontal lobe, may be related to anxiety-induced state changes. In addition, high fALFF levels in the right A13 and right A24cd subregions could serve as predictors for individual responses to antipsychotic therapy.

Open Access

Valproic acid ameliorates cauda equina injury by suppressing HDAC2-mediated ferroptosis

  • First Published: 17 December 2023
Valproic acid ameliorates cauda equina injury by suppressing HDAC2-mediated ferroptosis

Cauda equina injury (CEI) leads to ferroptosis in mice by raising the expression level of HDAC2, resulting in an increase in MDA and ROS. Ferroptosis in CEI is ameliorated by VPA treatment via suppressing HDAC2.

Open Access

The value of radiographic features in predicting postoperative facial nerve function in vestibular schwannoma patients: A retrospective study and nomogram analysis

  • First Published: 21 November 2023
The value of radiographic features in predicting postoperative facial nerve function in vestibular schwannoma patients: A retrospective study and nomogram analysis

The radiographic features, including tumor size, fundal fluid cap (FFC) and cerebrospinal fluid cleft (CSFC) sign, and the expansion of the IAC, may serve as good predictors of postoperative facial nerve (FN) outcomes after vestibular schwannoma resection.

Open Access

Icaritin greatly attenuates β-amyloid-induced toxicity in vivo

  • First Published: 21 November 2023
Icaritin greatly attenuates β-amyloid-induced toxicity in vivo

Icaritin greatly rescues the phenotypes of the Aβ-induced Drosophila AD model, and its possible mechanism is almost completely restoring the mitochondria damaged by the toxicity of Aβ.

Open Access

Self-Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma

  • First Published: 04 December 2023
Self-Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma

Enhancing the anti-tumor effect of PTX in GBM through self-assembled nanoparticles of natural bioactive molecules with anti P-gp activity, leading to improved water-solubility, BBB permeability, and chemosensitivity of PTX.

Open Access

Biallelic variants in the COQ4 gene caused hereditary spastic paraplegia predominant phenotype

  • First Published: 27 November 2023
Biallelic variants in the COQ4 gene caused hereditary spastic paraplegia predominant phenotype

Five COQ4 variants were identified in three Chinese HSP pedigrees. Functional studies revealed reduced CoQ10 level and fragmented mitochondria in patient's fibroblast.

Open Access

Dual-tDCS combined with sensorimotor training promotes upper limb function in subacute stroke patients: A randomized, double-blinded, sham-controlled study

  • First Published: 23 November 2023
Dual-tDCS combined with sensorimotor training promotes upper limb function in subacute stroke patients: A randomized, double-blinded, sham-controlled study

Dual-tDCS combined with sensorimotor training can improve upper limb sensory and motor dysfunction, enhance ADL, alleviate depression and anxiety, and enhance the functional connectivity of sensorimotor functional brain cortex for subacute stroke patients.

Open Access

Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study

  • First Published: 20 November 2023
Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study

With a lack of comprehensive comparisons among anti-Parkinson drugs (APDs), this multi-center retrospective study systematically compared the effectiveness, safety, and costs of different APDs. Carbidopa/levodopa or levodopa/benserazide might exhibit better clinical improvement with less medical cost, while piribedil presented less clinical improvement but a higher risk in headache/dizziness, gastrointestinal, and neuropsychiatric symptoms.

Open Access

Identification of mitophagy-associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease

  • First Published: 21 November 2023
Identification of mitophagy-associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease

Subjects with Parkinson's disease (PD) or PDs exhibit higher mitophagy-associated protein (MAP) levels compared to the CN group, but the differences in values between PD and PDs did not reach significance. The AUCs of PINK1, PGAM5, and Parkin were ranked as the top three MAP candidates in diagnosis accuracy for PD from CN. Higher plasma PINK1-Parkin levels and prominent diagnostic accuracy in A-syn (+) subjects are higher than in A-syn (−) subjects.

Open Access

Paraventricular thalamus-insular cortex circuit mediates colorectal visceral pain induced by neonatal colonic inflammation in mice

  • First Published: 23 November 2023
Paraventricular thalamus-insular cortex circuit mediates colorectal visceral pain induced by neonatal colonic inflammation in mice

A direct PVT-IC glutamate neural circuit playing a critical role in visceral hypersensitivity in a mouse model of IBS. This work will strengthen fundamental research on the involvement of central nervous system in visceral hyperalgesia and provide potential therapeutic targets toward effective treatment.

Open Access

Vof16-miR-185-5p-GAP43 network improves the outcomes following spinal cord injury via enhancing self-repair and promoting axonal growth

  • First Published: 02 January 2024
Vof16-miR-185-5p-GAP43 network improves the outcomes following spinal cord injury via enhancing self-repair and promoting axonal growth

Here, we found that vof16-miR185-5p-GAP43 network is closely related to SCT self-repair, and simultaneously enhances motor and sensory function after SCT. Knocking out vof16 or GAP43 could inhibit the self-repair of spinal cord and neurite growth, while miR-185-5p knockout promoted the axonal growth after SCT. Furthermore, miR-185-5p can competitively bind the same regulatory region of vof16 and GAP43. Our study provides a novel regulatory network that functions via a miRNA competitive mechanism mediated by vof16 in SCT self-repair and axonal growth.

Open Access

The phosphokinase activity of IRE1ɑ prevents the oxidative stress injury through miR-25/Nox4 pathway after ICH

  • First Published: 23 November 2023
The phosphokinase activity of IRE1ɑ prevents the oxidative stress injury through miR-25/Nox4 pathway after ICH

The proposed pathway by which IRE1α regulates the oxidative stress response via miR-25-3p/Nox4 after ICH. ① ICH induces ER stress and activates the phosphokinase activity of IRE1α. ② Self-phosphorylated IRE1ɑ increases the expression of miR-25-3p. ③ The complementary combination of miR-25-3p with Nox4 mRNA inhibits the translation of Nox4 mRNA and subsequently downregulated expression of Nox4, which leads to ROS production decrease, especially H2O2.

Open Access

Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using 18F-FDG PET/MRI Radiomics

  • First Published: 30 November 2023
Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using 18F-FDG PET/MRI Radiomics

This study aimed to investigate multiparametric imaging of the hippocampal radiomics for early diagnosis of AD using simultaneous PET/MRI. Our findings demonstrated that multi-dimensional imaging of the hippocampal radiomics benefits the identification of early AD (aMCI especially) and may provide a potential biomarker for clinical applications in AD.

Open Access

The effect of dopamine replacement therapy on cortical structure in Parkinson's disease

  • First Published: 23 November 2023
The effect of dopamine replacement therapy on cortical structure in Parkinson's disease

Significant cortical atrophy was primarily observed in the prefrontal cortex in DRT-treated patients, including bilateral superior frontal cortex (SFC) and left rostral anterior cingulate cortex (rACC). the left SFC volume was negatively correlated with levodopa equivalency dose (LED), as well as the left rACC volume and medication duration.

Open Access

Distinct alterations of retinal structure between thalamic and extra-thalamic subcortical infarction patients: A cross-sectional and longitudinal study

  • First Published: 29 November 2023
Distinct alterations of retinal structure between thalamic and extra-thalamic subcortical infarction patients: A cross-sectional and longitudinal study

We explored the cross-sectional and longitudinal retinal structural thicknesses in SSI patients based on their location. We showed at the baseline that thalamic infarction patients had thinner RNFL and GCIPL thicknesses compared with extra-thalamic stroke patients. Longitudinal analysis showed the thinning rate in GCIPL of the thalamic infarction group was significantly higher than that in the extra-thalamic infarction group.

Open Access

Disrupted topological organization of the default mode network in mild cognitive impairment with subsyndromal depression: A graph theoretical analysis

  • First Published: 17 December 2023
Disrupted topological organization of the default mode network in mild cognitive impairment with subsyndromal depression: A graph theoretical analysis

The global efficiency and nodal efficiency were significantly lower in mild cognitive impairment with SSD (MCID), and the accuracy of the support vector machine model was 0.83 for distinguishing MCID from MCIND. MCID is correlated to the greatest disrupted topological organization, which may serve as biomarkers of different MCI subgroups.

CORRIGENDUM

ORIGINAL ARTICLES

Open Access

Automatic sleep–wake classification and Parkinson's disease recognition using multifeature fusion with support vector machine

  • First Published: 11 April 2024
Automatic sleep–wake classification and Parkinson's disease recognition using multifeature fusion with support vector machine

This study utilized electrocorticographic (ECoG) power, electromyogram (EMG) amplitude, and corticomuscular coherence (CMC) values to construct sleep–wake scoring and Parkinson's disease (PD) prediction models based on the support vector machine (SVM) algorithm. The models enable precise classification and identification of sleep–wake states and exhibit robust performance across different rats.

Open Access

Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis

  • First Published: 11 April 2024
Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis

Nuclear autoantigenic sperm protein (NASP) plays a crucial role in glioblastoma progression and radioresistance, promotes DNA repair, and activates the STAT3 signaling pathway through ANXA2. The NASP/ANXA2/STAT3 axis is a potential therapeutic target for improving the prognosis of patients with GBM.

Open Access

Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma

  • First Published: 11 April 2024
Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma

Deep sequencing targeting DNA damage repair pathways identifies ARID1A as a prognostic biomarker for gliomas and its mutation alters SWI/SNF stability increasing the malignant phenotype of GBM and mediating chemoresistance.

REVIEWS

Open Access

Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy

  • First Published: 20 April 2024
Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy

Framework of identifying the multi-omics molecular biomarkers in brain tumor-related epilepsy (BTRE), including Genomics, Transcriptomics, Epigenomics, Proteomics, and Metabolomics, to facilitate the early diagnosis, etiological factors analysis, and personalized treatment of BTRE.

ORIGINAL ARTICLES

Open Access

Quercetin alleviates chronic unpredictable mild stress-induced depression-like behavior by inhibiting NMDAR1 with α2δ-1 in rats

  • First Published: 14 April 2024
Quercetin alleviates chronic unpredictable mild stress-induced depression-like behavior by inhibiting NMDAR1 with α2δ-1 in rats

Quercetin exerts antidepressant neuromodulation by inhibiting α2δ-1, interfering with the interaction between α2δ-1 and NMDAR, and reducing the expression of NMDAR.

Open Access

Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia–reperfusion injury

  • First Published: 14 April 2024
Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia–reperfusion injury

Astragaloside IV and Ligustrazine, the main ingredients of medicinal and food homologous plants Astragali Radix and Chuanxiong Rhizoma could ameliorate abnormal mitochondrial dynamics via the Drp1 SUMO/deSUMOylation following cerebral ischemia–reperfusion injury both in vivo and in vitro.

Open Access

The promotion-like effect of the M1-STN hyperdirect pathway induced by ccPAS enhanced balance performances: From the perspective of brain connectivity

  • First Published: 14 April 2024
The promotion-like effect of the M1-STN hyperdirect pathway induced by ccPAS enhanced balance performances: From the perspective of brain connectivity

The targeted stimulation of the hyperdirect pathway (M1-STN connectivity) with ccPAS enhanced the functional connectivity between the M1 and STN and subsequently enhanced the balance performance, highlighting the capability and efficacy of ccPAS in regulating brain connectivity associated with functional impairments.

Open Access

Brain white matter changes and their associations with non-motor dysfunction in orthostatic hypotension in α-synucleinopathy: A NODDI study

  • First Published: 14 April 2024
Brain white matter changes and their associations with non-motor dysfunction in orthostatic hypotension in α-synucleinopathy: A NODDI study

Patients with α-synucleinopathies experiencing OH exhibit distinctive patterns of microstructural damage in the WM as revealed by the NODDI model.

Open Access

Novel α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) potentiator LT-102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia

  • First Published: 14 April 2024
Novel α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) potentiator LT-102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia

The challenge of improving cognitive impairment associated with schizophrenia (CIAS) persists due to the limited availability of novel treatment options and drugs. Our study introduces a novel AMPAR potentiator, LT-102, which could be a potential therapeutic candidate for CIAS by modifying synaptic plasticity and glutamate signaling.

Open Access

Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III

  • First Published: 14 April 2024
Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III

We have demonstrated metabolic markers in CSF associated with the classification of SMA in children, including 4-chlorophenylacetic acid, sodium dodecyl benzenesulfonate, and cinobufagin. We also identified the metabolic pathways associated with the severity of SMA, including lysine degradation, arginine metabolism, and tyrosine metabolism.

Open Access

USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization

  • First Published: 21 April 2024
USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization

Deubiquitinase USP19 directly interacts with and deubiquitinates MGMT, which repairs the DNA methylation damage response. USP19 plays a critical role in DNA methylation damage repair and temozolomide treatment for GBM patients.

REVIEWS

Open Access

C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease

  • First Published: 21 April 2024
C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease

C/EBPβ overexpression exacerbates the pathologic progression of AD, primarily by promoting neuroinflammation and mediating transcriptional regulation of several disease-associated proteins, such as δ-secretase and APOE4. Additionally, C/EBPβ stimulates the upregulation of ANP32A and TRPC1, leading to elevated levels of phosphorylated Tau, while inhibiting the expression of FOXO, which is associated with genes involved in longevity. The in-depth research of the pathway through which C/EBPβ regulates the development of AD also reveals multiple vicious cycle pathways between C/EBPβ overexpression and the pathological progression of AD.

ORIGINAL ARTICLES

Open Access

Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study

  • First Published: 21 April 2024
Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study

This retrospective cohort study investigated the tolerability and efficacy of Anlotinib combined with the Stupp regimen for patients with H3K27M mutant diffuse midline glioma (DMG). Beyond establishing the safety profile, our study also identified encouraging benefits associated with Anlotinib treatment, particularly for patients with infratentorial DMG. These findings suggest that Anlotinib may represent a promising treatment option for H3K27M mutant DMG in the clinical setting.

Open Access

Brain areas interconnected to ventral pathway circuits are independently able to induce enhancement in object recognition memory and cause reversal in object recognition memory deficit

  • First Published: 21 April 2024
Brain areas interconnected to ventral pathway circuits are independently able to induce enhancement in object recognition memory and cause reversal in object recognition memory deficit

An increase in synaptic connectivity between each of the brain areas (perirhinal cortex is shown graph as an example) that are interconnected with ventral pathway circuits and ventral pathway circuits produces object recognition memory (ORM) enhancement and causes a reversal ORM deficit.

Open Access

Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1

  • First Published: 26 April 2024
Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1

Anxious behavior in mice with colitis was associated with an imbalance in hippocampal excitatory inhibition due to the overactivation of glutamate synapses. Peripheral suppression of colon inflammation or downregulation of GRM1 expression by AAV virus interference can significantly improve anxiety-like behavior.

REVIEWS

Open Access

CircRNA-associated ceRNA regulatory networks as emerging mechanisms governing the development and biophysiopathology of epilepsy

  • First Published: 26 April 2024
CircRNA-associated ceRNA regulatory networks as emerging mechanisms governing the development and biophysiopathology of epilepsy

CircRNA–miRNA–mRNA networks in epilepsy. CirRNAs can bind to microRNA response elements through sponging and regulate their expression downstream according to the competitive endogenous RNA hypothesis (ceRNA). The circRNA–miRNA–mRNA axes hold potential as valuable tools for comprehending the pathogenesis, diagnosis, and treatment of epilepsy. We summarize the possible regulatory networks of circRNA–miRNA–mRNA in epilepsy.